These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 14765384)

  • 1. Can chemotherapy replace radiotherapy in low-grade gliomas? Time for randomized studies.
    van den Bent MJ
    Semin Oncol; 2003 Dec; 30(6 Suppl 19):39-44. PubMed ID: 14765384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy for adult low-grade gliomas: clinical outcomes by molecular subtype in a phase II study of adjuvant temozolomide.
    Wahl M; Phillips JJ; Molinaro AM; Lin Y; Perry A; Haas-Kogan DA; Costello JF; Dayal M; Butowski N; Clarke JL; Prados M; Nelson S; Berger MS; Chang SM
    Neuro Oncol; 2017 Feb; 19(2):242-251. PubMed ID: 27571885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treating anaplastic oligodendrogliomas and WHO grade 2 gliomas: PCV or temozolomide? The case for PCV.
    Levin VA
    Oncology (Williston Park); 2015 Apr; 29(4):264, 266-8. PubMed ID: 25952490
    [No Abstract]   [Full Text] [Related]  

  • 4. Benefits of adjuvant chemotherapy in high-grade gliomas.
    DeAngelis LM
    Semin Oncol; 2003 Dec; 30(6 Suppl 19):15-8. PubMed ID: 14765379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temozolomide as first-line agent in treating high-grade gliomas: phase II study.
    Chibbaro S; Benvenuti L; Caprio A; Carnesecchi S; Pulerà F; Faggionato F; Serino D; Galli C; Andreuccetti M; Buxton N; Gagliardi R
    J Neurooncol; 2004; 67(1-2):77-81. PubMed ID: 15072451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treating anaplastic oligodendrogliomas and WHO grade 2 gliomas: PCV or temozolomide? The case for temozolomide.
    Rinne ML; Wen PY
    Oncology (Williston Park); 2015 Apr; 29(4):265, 275. PubMed ID: 25952491
    [No Abstract]   [Full Text] [Related]  

  • 7. NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide.
    Wick W; Hartmann C; Engel C; Stoffels M; Felsberg J; Stockhammer F; Sabel MC; Koeppen S; Ketter R; Meyermann R; Rapp M; Meisner C; Kortmann RD; Pietsch T; Wiestler OD; Ernemann U; Bamberg M; Reifenberger G; von Deimling A; Weller M
    J Clin Oncol; 2009 Dec; 27(35):5874-80. PubMed ID: 19901110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temozolomide and radiation in low-grade and anaplastic gliomas: temoradiation.
    Schiff D
    Cancer Invest; 2007 Dec; 25(8):776-84. PubMed ID: 17952745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An algorithm for chemotherapy treatment of recurrent glioma patients after temozolomide failure in the general oncology setting.
    Kyritsis AP; Levin VA
    Cancer Chemother Pharmacol; 2011 May; 67(5):971-83. PubMed ID: 21442438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapy for recurrent high-grade gliomas: does continuous dose-intense temozolomide have a role?
    Wen PY
    J Clin Oncol; 2010 Apr; 28(12):1977-9. PubMed ID: 20308652
    [No Abstract]   [Full Text] [Related]  

  • 11. Surgery, radiotherapy and temozolomide in treating high-grade gliomas.
    Parlato C; Barbarisi M; Moraci M; Moraci A
    Front Biosci; 2006 May; 11():1280-3. PubMed ID: 16368514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II study of protracted daily temozolomide for low-grade gliomas in adults.
    Kesari S; Schiff D; Drappatz J; LaFrankie D; Doherty L; Macklin EA; Muzikansky A; Santagata S; Ligon KL; Norden AD; Ciampa A; Bradshaw J; Levy B; Radakovic G; Ramakrishna N; Black PM; Wen PY
    Clin Cancer Res; 2009 Jan; 15(1):330-7. PubMed ID: 19118062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II study of primary temozolomide chemotherapy in patients with WHO grade II gliomas.
    Brada M; Viviers L; Abson C; Hines F; Britton J; Ashley S; Sardell S; Traish D; Gonsalves A; Wilkins P; Westbury C
    Ann Oncol; 2003 Dec; 14(12):1715-21. PubMed ID: 14630674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of temozolomide in recurrent malignant gliomas.
    Gaya A; Rees J; Greenstein A; Stebbing J
    Cancer Treat Rev; 2002 Apr; 28(2):115-20. PubMed ID: 12297119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promises and controversies in the management of low-grade glioma.
    Stupp R; Baumert BG
    Ann Oncol; 2003 Dec; 14(12):1695-6. PubMed ID: 14630671
    [No Abstract]   [Full Text] [Related]  

  • 16. Temozolomide for pediatric high-grade gliomas.
    Packer RJ
    Curr Neurol Neurosci Rep; 2012 Apr; 12(2):111-3. PubMed ID: 22249491
    [No Abstract]   [Full Text] [Related]  

  • 17. Temozolomide after radiotherapy for newly diagnosed high-grade glioma and unfavorable low-grade glioma in children.
    Broniscer A; Chintagumpala M; Fouladi M; Krasin MJ; Kocak M; Bowers DC; Iacono LC; Merchant TE; Stewart CF; Houghton PJ; Kun LE; Ledet D; Gajjar A
    J Neurooncol; 2006 Feb; 76(3):313-9. PubMed ID: 16200343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multicenter phase I trial of combination therapy with interferon-β and temozolomide for high-grade gliomas (INTEGRA study): the final report.
    Wakabayashi T; Kayama T; Nishikawa R; Takahashi H; Hashimoto N; Takahashi J; Aoki T; Sugiyama K; Ogura M; Natsume A; Yoshida J
    J Neurooncol; 2011 Sep; 104(2):573-7. PubMed ID: 21327711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carboplatin and oral cyclophosphamide combination after temozolomide failure in malignant gliomas.
    Yaman E; Buyukberber S; Uner A; Coskun U; Yamac D; Ozturk B; Kaya AO; Yildiz R; Benekli M;
    Tumori; 2008; 94(5):674-80. PubMed ID: 19112939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcome of low-grade oligodendroglioma and mixed glioma.
    Olson JD; Riedel E; DeAngelis LM
    Neurology; 2000 Apr; 54(7):1442-8. PubMed ID: 10751254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.